What is Labcorp Holdings Inc's earnings per share (EPS)?

Labcorp Holdings Inc (LH) reported diluted earnings per share of $10.46 for fiscal year 2025. This represents a 18.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Labcorp Holdings Inc Financials

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Labcorp Holdings Inc (LH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LH FY2025 2026-05-04

Labcorp’s recovery is being driven by margin rebuild and strong cash conversion, while the balance sheet remains acquisition-shaped.

FY2025 revenue reached $14.0B, above FY2021’s $13.1B, yet scale recovery did not bring back the earlier profit structure. Operating margin was 9.9% versus 23.2%, implying the business now earns materially less on each revenue dollar than it did at a similar revenue base.

From FY2023 to FY2025, operating income improved by $659M while SG&A rose only $195M. That pattern suggests the rebound came more from a healthier gross spread than from aggressive cuts to the overhead base, which matters because the recovery reflects core operating economics rather than simple austerity.

In FY2025, operating cash flow of $1.64B exceeded net income of $877M, so reported profit still translated into cash at a healthy rate. But cash on hand was only $532M against $5.08B of long-term debt, and with goodwill making up much of equity, the balance sheet looks acquisition-shaped rather than cash-rich.

Financial Health Signals

Financial Health Score 51/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Labcorp Holdings Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Labcorp Holdings Inc has an operating margin of 9.9%, meaning the company retains $10 of operating profit per $100 of revenue. This results in a moderate score of 62/100, indicating healthy but not exceptional operating efficiency. This is up from 8.3% the prior year.

Growth

Labcorp Holdings Inc's revenue grew 7.2% year-over-year to $14.0B, a solid pace of expansion. This earns a growth score of 58/100.

Leverage

Labcorp Holdings Inc has elevated debt relative to equity (D/E of 0.59), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 29/100, reflecting increased financial risk.

Liquidity

Labcorp Holdings Inc's current ratio of 1.42 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Labcorp Holdings Inc has a free cash flow margin of 8.6%, earning a moderate score of 62/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Labcorp Holdings Inc's ROE of 10.2% shows moderate profitability relative to equity, earning a score of 59/100. This is up from 9.3% the prior year.

Altman Z-Score Safe

3.11

Labcorp Holdings Inc scores 3.11, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

8/9

Labcorp Holdings Inc passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.87x

For every $1 of reported earnings, Labcorp Holdings Inc generates $1.87 in operating cash flow ($1.6B OCF vs $877.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

6.2x

Labcorp Holdings Inc earns $6.2 in operating income for every $1 of interest expense ($1.4B vs $224.1M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$14.0B

YoY+7.2%

5Y CAGR-0.0%

10Y CAGR+4.9%

Labcorp Holdings Inc generated $14.0B in revenue in fiscal year 2025. This represents an increase of 7.2% from the prior year.

EBITDA

$2.1B

YoY+19.4%

5Y CAGR-7.6%

10Y CAGR+3.6%

Labcorp Holdings Inc's EBITDA was $2.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 19.4% from the prior year.

Net Income

$877.0M

YoY+17.6%

5Y CAGR-10.8%

10Y CAGR+7.2%

Labcorp Holdings Inc reported $877.0M in net income in fiscal year 2025. This represents an increase of 17.6% from the prior year.

EPS (Diluted)

$10.46

YoY+18.3%

5Y CAGR-8.0%

10Y CAGR+9.2%

Labcorp Holdings Inc earned $10.46 per diluted share (EPS) in fiscal year 2025. This represents an increase of 18.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$1.2B

YoY+10.0%

5Y CAGR-7.2%

10Y CAGR+5.2%

Labcorp Holdings Inc generated $1.2B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 10.0% from the prior year.

Cash & Debt

$532.3M

YoY-65.0%

5Y CAGR-16.6%

10Y CAGR-2.9%

Labcorp Holdings Inc held $532.3M in cash against $5.1B in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.88

YoY+0.0%

Labcorp Holdings Inc paid $2.88 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding

82M

YoY-1.4%

5Y CAGR-3.4%

10Y CAGR-2.1%

Labcorp Holdings Inc had 82M shares outstanding in fiscal year 2025. This represents a decrease of 1.4% from the prior year.

Margins & Returns

Gross Margin

28.8%

YoY+0.9pp

5Y CAGR-6.7pp

10Y CAGR-4.7pp

Labcorp Holdings Inc's gross margin was 28.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.9 percentage points from the prior year.

Operating Margin

9.9%

YoY+1.6pp

5Y CAGR-7.6pp

10Y CAGR-1.6pp

Labcorp Holdings Inc's operating margin was 9.9% in fiscal year 2025, reflecting core business profitability. This is up 1.6 percentage points from the prior year.

Net Margin

6.3%

YoY+0.6pp

5Y CAGR-4.8pp

10Y CAGR+1.2pp

Labcorp Holdings Inc's net profit margin was 6.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.6 percentage points from the prior year.

Return on Equity

10.2%

YoY+0.9pp

5Y CAGR-6.3pp

10Y CAGR+1.3pp

Labcorp Holdings Inc's ROE was 10.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$450.0M

YoY+79.9%

5Y CAGR+35.1%

Labcorp Holdings Inc spent $450.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 79.9% from the prior year.

Capital Expenditures

$434.5M

YoY-11.3%

5Y CAGR+2.6%

10Y CAGR+5.4%

Labcorp Holdings Inc invested $434.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 11.3% from the prior year.

LH Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$14.0B+7.2%	$13.0B+7.0%	$12.2B+2.5%	$11.9B-9.7%	$13.1B-6.0%	$14.0B
Cost of Revenue	$9.9B+5.9%	$9.4B+6.7%	$8.8B+7.9%	$8.2B+0.1%	$8.1B-9.8%	$9.0B
Gross Profit	$4.0B+10.7%	$3.6B+7.7%	$3.4B-9.3%	$3.7B-25.7%	$5.0B+0.8%	$5.0B
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2.2B-0.6%	$2.2B+10.3%	$2.0B+14.7%	$1.8B+4.3%	$1.7B-2.3%	$1.7B
Operating Income	$1.4B+27.4%	$1.1B+49.8%	$725.6M-49.5%	$1.4B-52.9%	$3.0B+24.7%	$2.4B
Interest Expense	$224.1M+7.6%	$208.3M+4.4%	$199.6M+11.0%	$179.8M-15.1%	$211.8M+2.1%	$207.4M
Income Tax	$229.8M+8.2%	$212.4M+12.7%	$188.5M-19.4%	$233.9M-66.1%	$690.0M+4.2%	$662.1M
Net Income	$877.0M+17.6%	$746.0M+78.5%	$418.0M-67.3%	$1.3B-46.2%	$2.4B+52.8%	$1.6B
EPS (Diluted)	$10.46+18.3%	$8.84+85.3%	$4.77-65.9%	$13.97-42.7%	$24.39+53.6%	$15.88

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$3.5B+0.6%	$3.5B-1.3%	$3.6B+1.0%	$3.5B+5.4%	$3.3B+0.5%	$3.3B+1.4%	$3.3B+1.9%	$3.2B
Cost of Revenue	$2.5B0.0%	$2.5B-0.6%	$2.5B+2.3%	$2.5B+3.5%	$2.4B-1.5%	$2.4B+2.3%	$2.4B+3.6%	$2.3B
Gross Profit	$1.0B+2.1%	$993.2M-3.1%	$1.0B-2.0%	$1.0B+10.4%	$948.0M+5.8%	$896.3M-0.9%	$904.4M-2.4%	$926.4M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$551.0M+2.3%	$538.6M-2.5%	$552.4M-4.6%	$579.3M+6.1%	$546.0M-8.3%	$595.2M+4.7%	$568.6M+1.9%	$557.8M
Operating Income	$380.8M+42.3%	$267.6M-32.5%	$396.6M+0.5%	$394.5M+21.0%	$326.0M+50.6%	$216.5M-14.8%	$254.1M-13.8%	$294.8M
Interest Expense	$55.1M+0.2%	$55.0M-1.8%	$56.0M-1.9%	$57.1M+2.0%	$56.0M-11.7%	$63.4M+25.8%	$50.4M+5.9%	$47.6M
Income Tax	$41.7M+62.3%	$25.7M-66.0%	$75.5M+13.7%	$66.4M+6.8%	$62.2M+54.7%	$40.2M-2.0%	$41.0M-34.0%	$62.1M
Net Income	$277.8M+68.2%	$165.2M-36.7%	$261.1M+9.8%	$237.9M+11.8%	$212.8M+48.4%	$143.4M-15.3%	$169.3M-17.5%	$205.3M
EPS (Diluted)	$3.35	N/A	$3.12+9.9%	$2.84+12.7%	$2.52	N/A	$2.00-17.7%	$2.43

LH Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$18.4B+0.1%	$18.4B+9.9%	$16.7B-17.0%	$20.2B-1.1%	$20.4B+1.6%	$20.1B
Current Assets	$4.0B-16.4%	$4.8B+27.6%	$3.8B-18.6%	$4.6B-13.2%	$5.3B+4.0%	$5.1B
Cash & Equivalents	$532.3M-65.0%	$1.5B+182.9%	$536.8M+67.4%	$320.6M-78.2%	$1.5B+11.5%	$1.3B
Inventory	$534.7M+8.4%	$493.2M+3.9%	$474.6M+0.8%	$470.6M+17.2%	$401.4M-5.2%	$423.2M
Accounts Receivable	$2.1B+8.2%	$1.9B+1.6%	$1.9B+7.2%	$1.8B-21.0%	$2.3B-8.8%	$2.5B
Goodwill	$6.8B+6.6%	$6.4B+3.7%	$6.1B+0.3%	$6.1B+4.0%	$5.9B-24.0%	$7.8B
Total Liabilities	$9.8B-5.4%	$10.3B+16.7%	$8.8B-12.0%	$10.0B-0.5%	$10.1B-4.9%	$10.6B
Current Liabilities	$2.8B-15.2%	$3.3B+3.3%	$3.2B+4.8%	$3.1B+10.6%	$2.8B-9.6%	$3.1B
Long-Term Debt	$5.1B-4.6%	$5.3B+31.5%	$4.1B-19.5%	$5.0B-7.0%	$5.4B0.0%	$5.4B
Total Equity	$8.6B+7.0%	$8.1B+2.3%	$7.9B-22.0%	$10.1B-1.7%	$10.3B+8.9%	$9.4B
Retained Earnings	$8.6B+4.1%	$8.3B+5.3%	$7.9B-25.5%	$10.6B+1.2%	$10.5B+10.3%	$9.5B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$19.1B+3.8%	$18.4B+0.7%	$18.3B+1.1%	$18.1B+2.6%	$17.6B-4.2%	$18.4B-1.3%	$18.6B+11.4%	$16.7B
Current Assets	$4.6B+13.4%	$4.0B-1.4%	$4.1B-0.2%	$4.1B+7.9%	$3.8B-21.2%	$4.8B-2.1%	$4.9B+37.5%	$3.6B
Cash & Equivalents	$981.1M+84.3%	$532.3M-11.0%	$598.1M-7.6%	$647.3M+75.2%	$369.4M-75.7%	$1.5B+0.1%	$1.5B+472.4%	$265.1M
Inventory	$497.7M-6.9%	$534.7M+2.5%	$521.5M+2.6%	$508.1M+4.1%	$488.3M-1.0%	$493.2M+2.1%	$483.1M+9.3%	$441.8M
Accounts Receivable	$2.3B+8.8%	$2.1B-0.3%	$2.1B-0.5%	$2.1B-0.1%	$2.1B+9.2%	$1.9B-5.6%	$2.1B-1.5%	$2.1B
Goodwill	$7.0B+2.4%	$6.8B+1.6%	$6.7B+2.0%	$6.6B+2.0%	$6.4B+0.8%	$6.4B-1.7%	$6.5B+4.2%	$6.2B
Total Liabilities	$10.3B+6.0%	$9.8B+2.2%	$9.5B-0.2%	$9.6B+3.1%	$9.3B-10.0%	$10.3B-1.1%	$10.4B+20.0%	$8.7B
Current Liabilities	$2.6B-6.5%	$2.8B+7.4%	$2.6B-3.2%	$2.7B+31.6%	$2.1B-38.0%	$3.3B-2.4%	$3.4B-16.1%	$4.1B
Long-Term Debt	$5.8B+14.7%	$5.1B0.0%	$5.1B+0.1%	$5.1B-8.8%	$5.6B+4.5%	$5.3B-0.4%	$5.4B+75.6%	$3.0B
Total Equity	$8.7B+1.3%	$8.6B-0.9%	$8.7B+2.6%	$8.5B+2.0%	$8.3B+3.2%	$8.1B-1.4%	$8.2B+2.1%	$8.0B
Retained Earnings	$8.8B+1.7%	$8.6B-0.7%	$8.7B+2.4%	$8.5B+0.5%	$8.5B+1.8%	$8.3B+0.3%	$8.3B+1.2%	$8.2B

LH Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$1.6B+3.4%	$1.6B+19.4%	$1.3B-32.1%	$2.0B-37.1%	$3.1B+45.6%	$2.1B
Capital Expenditures	$434.5M-11.3%	$489.9M+8.0%	$453.6M+5.7%	$429.3M+1.9%	$421.5M+10.4%	$381.7M
Free Cash Flow	$1.2B+10.0%	$1.1B+25.4%	$874.1M-42.7%	$1.5B-43.2%	$2.7B+53.3%	$1.8B
Investing Cash Flow	-$1.2B+12.6%	-$1.4B-16.7%	-$1.2B+29.1%	-$1.7B-86.8%	-$884.6M-37.5%	-$643.2M
Financing Cash Flow	-$1.5B-286.8%	$779.9M+1415.2%	-$59.3M+95.5%	-$1.3B+36.0%	-$2.1B-299.3%	-$517.4M
Dividends Paid	$240.7M-1.0%	$243.1M-4.3%	$254.0M+30.1%	$195.2M	N/A	N/A
Share Buybacks	$450.0M+79.9%	$250.1M-75.0%	$1.0B-9.1%	$1.1B-34.1%	$1.7B+1568.5%	$100.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$191.5M-68.8%	$614.2M+58.6%	$387.2M-37.6%	$620.6M+3254.6%	$18.5M-97.6%	$777.2M+180.3%	$277.3M-50.6%	$561.1M
Capital Expenditures	$121.0M-2.3%	$123.9M+16.1%	$106.7M+37.0%	$77.9M-38.2%	$126.0M+12.4%	$112.1M-3.2%	$115.8M-9.7%	$128.2M
Free Cash Flow	$70.5M-85.6%	$490.3M+74.8%	$280.5M-48.3%	$542.7M+604.8%	-$107.5M-116.2%	$665.1M+311.8%	$161.5M-62.7%	$432.9M
Investing Cash Flow	-$322.1M+17.4%	-$389.9M-4.3%	-$374.0M-297.4%	-$94.1M+72.0%	-$336.0M-60.3%	-$209.6M+63.8%	-$579.1M-213.0%	-$185.0M
Financing Cash Flow	$580.5M+299.9%	-$290.4M-388.1%	-$59.5M+77.7%	-$267.4M+68.2%	-$839.7M-53.6%	-$546.7M-135.3%	$1.5B+837.3%	-$210.0M
Dividends Paid	$61.2M+3.2%	$59.3M-2.3%	$60.7M+0.8%	$60.2M-2.3%	$61.6M+2.5%	$60.1M-1.6%	$61.1M+1.5%	$60.2M
Share Buybacks	$98.0M-56.4%	$225.0M+800.0%	$25.0M-87.5%	$200.0M	$0-100.0%	$75.1M+0.1%	$75.0M	N/A

LH Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	28.8%+0.9pp	27.9%+0.2pp	27.7%-3.6pp	31.3%-6.8pp	38.0%+2.6pp	35.4%
Operating Margin	9.9%+1.6pp	8.3%+2.4pp	6.0%-6.1pp	12.1%-11.1pp	23.2%+5.7pp	17.5%
Net Margin	6.3%+0.6pp	5.7%+2.3pp	3.4%-7.3pp	10.8%-7.3pp	18.1%+7.0pp	11.1%
Return on Equity	10.2%+0.9pp	9.3%+4.0pp	5.3%-7.4pp	12.7%-10.5pp	23.1%+6.7pp	16.5%
Return on Assets	4.8%+0.7pp	4.1%+1.6pp	2.5%-3.9pp	6.3%-5.3pp	11.7%+3.9pp	7.8%
Current Ratio	1.42-0.0	1.44+0.3	1.17-0.3	1.50-0.4	1.92+0.3	1.66
Debt-to-Equity	0.59-0.1	0.66+0.1	0.51+0.0	0.50-0.0	0.53-0.0	0.57
FCF Margin	8.6%+0.2pp	8.4%+1.2pp	7.2%-5.7pp	12.9%-7.6pp	20.5%+7.9pp	12.5%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	28.7%+0.4pp	28.2%-0.5pp	28.8%-0.9pp	29.7%+1.3pp	28.3%+1.4pp	26.9%-0.6pp	27.6%-1.2pp	28.8%
Operating Margin	10.8%+3.1pp	7.6%-3.5pp	11.1%-0.1pp	11.2%+1.4pp	9.8%+3.3pp	6.5%-1.2pp	7.7%-1.4pp	9.2%
Net Margin	7.8%+3.1pp	4.7%-2.6pp	7.3%+0.6pp	6.7%+0.4pp	6.4%+2.1pp	4.3%-0.9pp	5.2%-1.2pp	6.4%
Return on Equity	3.2%+1.3pp	1.9%-1.1pp	3.0%+0.2pp	2.8%+0.2pp	2.6%+0.8pp	1.8%-0.3pp	2.1%-0.5pp	2.6%
Return on Assets	1.5%+0.6pp	0.9%-0.5pp	1.4%+0.1pp	1.3%+0.1pp	1.2%+0.4pp	0.8%-0.1pp	0.9%-0.3pp	1.2%
Current Ratio	1.73+0.3	1.42-0.1	1.55+0.0	1.50-0.3	1.84+0.4	1.440.0	1.44+0.6	0.88
Debt-to-Equity	0.67+0.1	0.590.0	0.58-0.0	0.60-0.1	0.670.0	0.660.0	0.66+0.3	0.38
FCF Margin	2.0%-12.0pp	14.0%+6.1pp	7.9%-7.5pp	15.4%+18.6pp	-3.2%-23.2pp	20.0%+15.1pp	4.9%-8.5pp	13.4%

Similar Companies

Quest Diagnostics Inc DGX

$22.3B

$39.7B

$26.6B

$36.8B

$34.5B

Frequently Asked Questions

What is Labcorp Holdings Inc's annual revenue?

Labcorp Holdings Inc (LH) reported $14.0B in total revenue for fiscal year 2025. This represents a 7.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Labcorp Holdings Inc's revenue growing?

Labcorp Holdings Inc (LH) revenue grew by 7.2% year-over-year, from $13.0B to $14.0B in fiscal year 2025.

Is Labcorp Holdings Inc profitable?

Yes, Labcorp Holdings Inc (LH) reported a net income of $877.0M in fiscal year 2025, with a net profit margin of 6.3%.

What is Labcorp Holdings Inc's EBITDA?

Labcorp Holdings Inc (LH) had EBITDA of $2.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Labcorp Holdings Inc have?

As of fiscal year 2025, Labcorp Holdings Inc (LH) had $532.3M in cash and equivalents against $5.1B in long-term debt.

What is Labcorp Holdings Inc's gross margin?

Labcorp Holdings Inc (LH) had a gross margin of 28.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Labcorp Holdings Inc's operating margin?

Labcorp Holdings Inc (LH) had an operating margin of 9.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Labcorp Holdings Inc's net profit margin?

Labcorp Holdings Inc (LH) had a net profit margin of 6.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Labcorp Holdings Inc pay dividends?

Yes, Labcorp Holdings Inc (LH) paid $2.88 per share in dividends during fiscal year 2025.

What is Labcorp Holdings Inc's return on equity (ROE)?

Labcorp Holdings Inc (LH) has a return on equity of 10.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Labcorp Holdings Inc's free cash flow?

Labcorp Holdings Inc (LH) generated $1.2B in free cash flow during fiscal year 2025. This represents a 10.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Labcorp Holdings Inc's operating cash flow?

Labcorp Holdings Inc (LH) generated $1.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Labcorp Holdings Inc's total assets?

Labcorp Holdings Inc (LH) had $18.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Labcorp Holdings Inc's capital expenditures?

Labcorp Holdings Inc (LH) invested $434.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Labcorp Holdings Inc buy back shares?

Yes, Labcorp Holdings Inc (LH) spent $450.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Labcorp Holdings Inc have outstanding?

Labcorp Holdings Inc (LH) had 82M shares outstanding as of fiscal year 2025.

What is Labcorp Holdings Inc's current ratio?

Labcorp Holdings Inc (LH) had a current ratio of 1.42 as of fiscal year 2025, which is considered adequate.

What is Labcorp Holdings Inc's debt-to-equity ratio?

Labcorp Holdings Inc (LH) had a debt-to-equity ratio of 0.59 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Labcorp Holdings Inc's return on assets (ROA)?

Labcorp Holdings Inc (LH) had a return on assets of 4.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Labcorp Holdings Inc's Altman Z-Score?

Labcorp Holdings Inc (LH) has an Altman Z-Score of 3.11, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Labcorp Holdings Inc's Piotroski F-Score?

Labcorp Holdings Inc (LH) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Labcorp Holdings Inc's earnings high quality?

Labcorp Holdings Inc (LH) has an earnings quality ratio of 1.87x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Labcorp Holdings Inc cover its interest payments?

Labcorp Holdings Inc (LH) has an interest coverage ratio of 6.2x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Labcorp Holdings Inc?

Labcorp Holdings Inc (LH) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.